human-derived sertoli cell therapy (Everlife Biomed)

N/A

Report date: 2025/03/20 15:00:21

Base Information

Drug Namehuman-derived sertoli cell therapy (Everlife Biomed)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEverlife Biomed Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverlife Biomed Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A